Browsing Tag
AI Cancer Diagnostics
3 posts
Median Technologies secures €37.5m EIB funding to advance eyonis AI cancer diagnostics and US launch
Median Technologies secures €37.5M from the European Investment Bank to accelerate AI-driven eyonis® cancer screening software commercialization in the US and EU.
July 14, 2025
Lunit acquires Volpara Health Technologies to advance AI in cancer diagnostics
Lunit, a leader in AI-powered solutions for cancer diagnostics and therapeutics, has completed its acquisition of Volpara Health…
May 23, 2024
Lunit announces strategic partnerships to advance AI in cancer diagnostics across Europe
Lunit (KRX:328130.KQ), a frontrunner in AI-powered solutions for cancer diagnostics and therapeutics, is marking a significant milestone in…
March 19, 2024